Thermo Fisher Scientific Inc.
TMO Healthcare Diagnostics & Research
Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024.
- Revenue
- +9.13%
- EPS
- +8.64%
- Free cash flow
- +15.0%
- Total debt
- +22.8%
Quarter to September 2026, against a year earlier
Follow TMO
Alert me
Thermo Fisher Scientific Inc. (TMO) Book value per share
Thermo Fisher Scientific Inc.'s book value per share at the end of fiscal 2025 was 142×, up 9.23% from 130× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 148×. Over the past ten years it has ranged from 53.5× (fiscal 2015) to 142× (fiscal 2025) — the current reading is the highest in ten years. Thermo Fisher Scientific Inc. ranks 2nd of 49 Diagnostics & Research companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 142× | 9.23% |
| FY2024 | 130× | 7.16% |
| FY2023 | 121× | 7.76% |
| FY2022 | 112× | 8.33% |
| FY2021 | 104× | 18.96% |
| FY2020 | 87.2× | 17.49% |
| FY2019 | 74.2× | 8.11% |
| FY2018 | 68.6× | 6.66% |
| FY2017 | 64.3× | 17.98% |
| FY2016 | 54.5× | 1.91% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 148× | 4.23% |
| Jun 2026 | 142× | 1.71% |
| Mar 2026 | 140× | (1.45%) |
| Dec 2025 | 142× | 4.96% |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| WAT Waters Corporation compare | 156× |
| TMO Thermo Fisher Scientific Inc. | 148× |
| DHR Danaher Corporation compare | 76.2× |
| IQV IQVIA Holdings Inc. compare | 41.2× |
| A Agilent Technologies, Inc. compare | 26.1× |
| IDXX IDEXX Laboratories, Inc. compare | 23.7× |
| ILMN Illumina, Inc. compare | 20.8× |
| NTRA Natera, Inc. compare | 13.0× |
| MTD Mettler-Toledo International, Inc. compare | 0.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on TMO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement